切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2020, Vol. 08 ›› Issue (01) : 28 -32. doi: 10.3877/cma.j.issn.2095-5782.2020.01.007

所属专题: 文献

神经介入

Pipeline Flex血流导向装置治疗颅内复杂动脉瘤的安全性及短期疗效
吴桥伟1, 李立1, 邵秋季1, 李天晓1,(), 贺迎坤1,(), 常凯涛1, 白卫星1   
  1. 1. 450003 河南郑州,郑州大学人民医院介入中心脑血管病科、河南省人民医院、河南大学人民医院、河南省神经介入研发与应用工程研究中心
  • 收稿日期:2020-01-23 出版日期:2020-02-25
  • 通信作者: 李天晓, 贺迎坤
  • 基金资助:
    "十三五"国家重点研发计划项目(2016YFC1300702); 国家自然科学基金项目(81601583)

Safety and efficacy analysis of Pipeline Flex embolization device for treatment of complex intracranial aneurysms

Qiaowei Wu1, Li Li1, Qiuji Shao1, Tianxiao Li1,(), Yingkun He1,(), Kaitao Chang1, Weixin Bai1   

  1. 1. Department of Cerebrovascular Disease, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Henan Provincial Neurointerventional Engineering Research Center, Henan Zhengzhou 450003, China
引用本文:

吴桥伟, 李立, 邵秋季, 李天晓, 贺迎坤, 常凯涛, 白卫星. Pipeline Flex血流导向装置治疗颅内复杂动脉瘤的安全性及短期疗效[J/OL]. 中华介入放射学电子杂志, 2020, 08(01): 28-32.

Qiaowei Wu, Li Li, Qiuji Shao, Tianxiao Li, Yingkun He, Kaitao Chang, Weixin Bai. Safety and efficacy analysis of Pipeline Flex embolization device for treatment of complex intracranial aneurysms[J/OL]. Chinese Journal of Interventional Radiology(Electronic Edition), 2020, 08(01): 28-32.

目的

评价第2代Pipeline血流导向装置(PED Flex)治疗颅内复杂动脉瘤的安全性及短期疗效。

方法

回顾性分析郑州大学人民医院2018年1月至2019年8月应用PED Flex治疗颅内复杂动脉瘤患者的临床及影像学资料,分析围手术期神经系统并发症情况,采用改良Rankin量表(mRS)评分评价患者临床预后;影像学随访采用O'Kelly-Marotta(OKM)分级评估动脉瘤闭塞情况。

结果

131例患者共应用144枚PED Flex治疗159个动脉瘤,手术成功率为100%。其中107个动脉瘤采用单纯支架置入,52个动脉瘤结合弹簧圈填塞。术后神经系统并发症发生率为3.1%(4/131),其中缺血性并发症发生率为2.3%(3/131),出血性并发症发生率为0.8%(1/131),无死亡病例,出院mRS 0分101例,1分25例,2分4例,4分1例,致残率为0.8%(1/131)。61例患者共80个动脉瘤获影像学随访,末次中位随访时间6.0(3~9)个月,动脉瘤完全闭塞(OKM分级D级)57个,完全闭塞率为71.3%(57/80);支架内狭窄4(6.6%,4/61)例,均无神经系统症状。87例患者获临床随访,中位随访时间为9.0(2~21)个月,mRS 0分78例,1分5例,2分3例,4分1例。

结论

PED Flex治疗颅内复杂动脉瘤手术成功率高,安全性较好;术后6个月随访完全闭塞率高,疗效良好。

Objective

To evaluate the safety and short-term efficacy of Pipeline Flex embolization device (PED Flex) for treatment of complex intracranial aneurysms.

Methods

The clinical data of131 patients with complex intracranial aneurysms who were treated with PED Flex in Zhengzhou university People's Hospital from June 2018 to August 2019 were retrospectively analyzed. Periprocedural complications were analyzed. Modified Rankin Scale (mRS) was used to evaluate clinical outcomes and the O’Kelly-Marotta (OKM)grading scale was used to evaluate imaging outcomes.

Results

A total of 131 patients with159 complex aneurysms were treated with 144 PED Flex, and the procedure success rate was 100%. Adjunctive coiling was used in 52 aneurysms and 107 cases used the stent only. Postprocedural neurological complication rate was 3.1% (4/131). Among them, the thromboembolic and hemorrhagic complication was 2.3%(3/131) and 0.8%(1/131), respectively. There were no deaths occurred. The mRS were 0 in 101 patients, 1 in 25, 2 in 4,4 in 1 and the disability rate was 0.8%(1/131) at discharge. A total of 61 patients with 80 aneurysms obtained the imaging follow-up with a median of 6.0(3-9) months. Fifty-seven aneurysms were completely occluded (grade D of OKM grading scale) with a complete occlusion rate of 71.3%(57/80). The in-stent stenosis was observed in 4 (6.6%, 4/61) patients, but no patients were symptomatic. Eighty-seven patients obtained the clinical follow-up with a median of 9.0 (2-21) months, and the mRS were 0 in 78 patients, 1 in 5, 2 in 3 and 4 in 1.

Conclusions

The treatment of complex intracranial aneurysms with PED Flex is safe with a high procedure success rate, and it is efficient with a high complete occlusion rate during the 6-months follow-up.

图1 巨大动脉瘤患者(女,65岁,因频繁恶心、呕吐入院)的术前后DSA图像
[1]
Rho MH, Park HJ, Chung EC, et al. Various techniques of stent-assisted coil embolization of wide-necked or fusiform artherosclerotic and dissecting unruptured vertebrobasilar artery aneurysms for reducing recanalization: mid-term results[J]. Acta neurochirurgica, 2013, 155(11): 2009-2017. DOI: 10.1007/s00701-013-1866-y.
[2]
Becske T, Kallmes DF, Saatci I, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial[J]. Radiology, 2013, 267(3): 858-868. DOI: 10.1148/radiol.13120099.
[3]
李航,贺迎坤,白卫星,等.Pipeline血流导向装置治疗复杂颅内动脉瘤的安全性及中期疗效[J].中华神经外科杂志,2018, 34(5): 442-6. DOI: 10.3760/cma.j.issn.1001-2346.2018.05.003.
[4]
Kallmes DF, Ding YH, Dai D,et al. A new endoluminal, flow-disrupting device for treatment of saccular aneurysms[J]. Stroke, 2007, 38(8): 2346-2352. DOI: 10.1161/STROKEAHA.106.479576.
[5]
Duckworth EA, Nickele C, Hoit D, et al. The first North American use of the Pipeline Flex flow diverter[J]. Journal of neurointerventional surgery, 2016, 8(2): e8. DOI: 10.1136/neurintsurg-2014-011548.rep.
[6]
Martínez-Galdámez M, Gil A, Caniego JL, et al. Preliminary experience with the Pipeline Flex Embolization Device: technical note[J]. Journal of neurointerventional surgery, 2015, 7(10): 748-751. DOI: 10.1136/neurintsurg-2014-011385.
[7]
O'kelly CJ, Krings T, Fiorella D. A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents[J]. Interventional neuroradiology, 2010, 16(2): 133-137. DOI: 10.1177/159101991001600204.
[8]
Radaelli AG, Augsburger L, Cebral JR, et al. Reproducibility of haemodynamical simulations in a subject-specific stented aneurysm model--a report on the Virtual Intracranial Stenting Challenge 2007[J]. Journal of biomechanics, 2008, 41(10): 2069-2081. DOI: 10.1016/j.jbiomech.2008.04.035.
[9]
Szikora I, Berentei Z, Kulcsar Z, et al. Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device[J]. AJNR. American journal of neuroradiology, 2010, 31(6): 1139-1147. DOI:10.3174/ajnr.A2023.
[10]
Wong GK, Kwan MC, Ng RY, et al. Flow diverters for treatment of intracranial aneurysms: current status and ongoing clinical trials[J]. Journal of clinical neuroscience, 2011, 18(6): 737-740. DOI: 10.1016/j.jocn.2010.10.011.
[11]
Jabbour P, Chalouhi N, Tjoumakaris S, et al. The Pipeline Embolization Device: learning curve and predictors of complications and aneurysm obliteration[J]. Neurosurgery, 2013, 73(1): 113-20; discussion 120. DOI: 10.1227/01.neu.0000429844.06955.39.
[12]
Pereira VM, Kelly M, Vega P, et al. New Pipeline Flex device: initial experience and technical nuances[J]. Journal of neurointerventional surgery, 2015, 7(12): 920-925. DOI: 10.1136/neurintsurg-2014-011347.
[13]
Colby GP, Bender MT, Lin LM, et al. Declining complication rates with flow diversion of anterior circulation aneurysms after introduction of the Pipeline Flex: analysis of a single-institution series of 568 cases[J]. Journal of neurosurgery, 2018, 129(6): 1475-1481. DOI: 10.3171/2017.7.JNS171289.
[14]
Brasiliense LBC, Aguilar-Salinas P, Lopes DK, et al. Multicenter Study of Pipeline Flex for Intracranial Aneurysms[J]. Neurosurgery, 2019, 84(6): E402-E409. DOI: 10.1093/neuros/nyy422.
[15]
Ge H,Yang H,Ren H,et al.Association of thrombelastographic parameters with complications in patients with intracranial aneurysm after stent placement[J]. World neurosurgery, 2019, 127: e30-e38. DOI: 10.1016/j.wneu.2019.02.007.
[16]
Adeeb N, Griessenauer CJ, Foreman PM, et al. Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study[J]. Stroke, 2017, 48(5): 1322-1330. DOI: 10.1161/STROKEAHA.116.015308.
[17]
Zi-Liang W, Xiao-Dong L, Tian-Xiao L, et al. Intravenous administration of tirofiban versus loading dose of oral clopidogrel for preventing thromboembolism in stent-assisted coiling of intracranial aneurysms[J]. International journal of stroke, 2017, 12(5): 553-559. DOI: 10.1177/1747493016677989.
[18]
Kallmes D F, Brinjikji W, Cekirge S, et al. Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies[J]. J Neurosurg, 2017, 127(4): 775-80. DOI: 10.3171/2016.8.JNS16467.
[19]
Marosfoi M, Langan ET, Strittmatter L, et al. In situ tissue engineering: endothelial growth patterns as a function of flow diverter design[J]. Journal of neurointerventional surgery, 2017, 9(10): 994-998. DOI:10.1136/neurintsurg-2016-012669.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[9] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[10] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[11] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[12] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[13] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[14] 王学虎, 赵渝. 复杂腹壁疝手术中血管损伤并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 616-619.
[15] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
阅读次数
全文


摘要